Blockbuster Oncology Brands Market Size, Share & Trends Report

Blockbuster Oncology Brands Market Size, Share & Trends Analysis Report By Brand (Opdivo, Revlimid, Zejula), By Indication (Lung Cancer, Lymphoma, Multiple Myeloma), And Segment Forecasts, 2018 - 2027

  • Report ID: GVR-2-68038-603-5
  • Number of Pages: 170
  • Format: Electronic (PDF)
  • Historical Range: 2015 - 2016
  • Industry: Healthcare

Market Segmentation

  • Blockbuster Oncology Brands Outlook (Revenue, USD Million, 2015 - 2027)
    • Opdivo
    • Keytruda
    • Perjeta
    • Ibrance
    • Tecentriq
    • Gazyva
    • Tagrisso
    • Darzalex
    • Zejula
    • Revlimid
    • Imbruvica
  • Blockbuster Oncology Brands Indication Outlook (Revenue, USD Million, 2015 - 2027)
    • Lung cancer
    • Breast cancer
    • Multiple myeloma
    • Lymphoma
    • Others
  • Blockbuster Oncology Brands Regional Outlook (Revenue, USD Million, 2015 - 2027)
    • North America
      • North America Blockbuster Oncology Brands Market, by Brands
        • Opdivo
        • Keytruda
        • Perjeta
        • Ibrance
        • Tecentriq
        • Gazyva
        • Tagrisso
        • Darzalex
        • Zejula
        • Revlimid
        • Imbruvica
      • North America Blockbuster Oncology Brands Market, by Indication
        • Lung cancer
        • Breast cancer
        • Multiple myeloma
        • Lymphoma
        • Others
      • The U.S.
        • The U.S. Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • The U.S. Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Canada
        • Canada Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Canada Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
    • Europe
      • Europe Blockbuster Oncology Brands Market, by Brands
        • Opdivo
        • Keytruda
        • Perjeta
        • Ibrance
        • Tecentriq
        • Gazyva
        • Tagrisso
        • Darzalex
        • Zejula
        • Revlimid
        • Imbruvica
      • Europe Blockbuster Oncology Brands Market, by Indication
        • Lung cancer
        • Breast cancer
        • Multiple myeloma
        • Lymphoma
        • Others
      • The U.K.
        • The U.K. Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • The U.K. Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Germany
        • Germany Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Germany Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Italy
        • Italy Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Italy Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Switzerland
        • Switzerland Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Switzerland Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • France
        • France Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • France Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Spain
        • Spain Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Spain Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Poland
        • Poland Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Poland Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Denmark
        • Denmark Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Denmark Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
    • Asia Pacific
      • Asia Pacific Blockbuster Oncology Brands Market, by Brands
        • Opdivo
        • Keytruda
        • Perjeta
        • Ibrance
        • Tecentriq
        • Gazyva
        • Tagrisso
        • Darzalex
        • Zejula
        • Revlimid
        • Imbruvica
      • Asia Pacific Blockbuster Oncology Brands Market, by Indication
        • Lung cancer
        • Breast cancer
        • Multiple myeloma
        • Lymphoma
        • Others
      • Japan
        • Japan Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Japan Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • China
        • China Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • China Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • India
        • India Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • India Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Australia
        • Australia Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Australia Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • New Zealand
        • New Zealand Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • New Zealand Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Hong Kong
        • Hong Kong Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Hong Kong Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Singapore
        • Singapore Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Singapore Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Philippines
        • Philippines Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Philippines Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • South Korea
        • South Korea Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • South Korea Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Indonesia
        • Indonesia Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Indonesia Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
    • Latin America
      • Latin America Blockbuster Oncology Brands Market, by Brands
        • Opdivo
        • Keytruda
        • Perjeta
        • Ibrance
        • Tecentriq
        • Gazyva
        • Tagrisso
        • Darzalex
        • Zejula
        • Revlimid
        • Imbruvica
      • Latin America Blockbuster Oncology Brands Market, by Indication
        • Lung cancer
        • Breast cancer
        • Multiple myeloma
        • Lymphoma
        • Others
      • Brazil
        • Brazil Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Brazil  Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Mexico
        • Mexico Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Mexico Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Argentina
        • Argentina Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Argentina Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
    • The Middle East & Africa
      • The Middle East & Africa Blockbuster Oncology Brands Market, by Brands
        • Opdivo
        • Keytruda
        • Perjeta
        • Ibrance
        • Tecentriq
        • Gazyva
        • Tagrisso
        • Darzalex
        • Zejula
        • Revlimid
        • Imbruvica
      • The Middle East & Africa Blockbuster Oncology Brands Market, by Indication
        • Lung cancer
        • Breast cancer
        • Multiple myeloma
        • Lymphoma
        • Others
      • Israel
        • Israel Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Israel Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Turkey
        • Turkey Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Turkey Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others
      • Saudi Arabia
        • Saudi Arabia Blockbuster Oncology Brands Market, by Brands
          • Opdivo
          • Keytruda
          • Perjeta
          • Ibrance
          • Tecentriq
          • Gazyva
          • Tagrisso
          • Darzalex
          • Zejula
          • Revlimid
          • Imbruvica
        • Saudi Arabia Blockbuster Oncology Brands Market, by Indication
          • Lung cancer
          • Breast cancer
          • Multiple myeloma
          • Lymphoma
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2015 to 2027
  • Market estimates and forecast for product segments up to 2027
  • Regional market size and forecast for product segments up to 2027
  • Market estimates and forecast for application segments up to 2027
  • Regional market size and forecast for application segments up to 2027
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.